The Road to Precision Medicine for Acute Kidney Injury

 

by Birkelo, Bethany C.; Koyner, Jay L.; Ostermann, Marlies; Bhatraju, Pavan K. 

 

Critical Care Medicine 52(7): p 1127-1137, July 2024.

OBJECTIVES: 

Acute kidney injury (AKI) is a common form of organ dysfunction in the ICU. AKI is associated with adverse short- and long-term outcomes, including high mortality rates, which have not measurably improved over the past decade. This review summarizes the available literature examining the evidence of the need for precision medicine in AKI in critical illness, highlights the current evidence for heterogeneity in the field of AKI, discusses the progress made in advancing precision in AKI, and provides a roadmap for studying precision-guided care in AKI.

DATA SOURCES: 

Medical literature regarding topics relevant to precision medicine in AKI, including AKI definitions, epidemiology, and outcomes, novel AKI biomarkers, studies of electronic health records (EHRs), clinical trial design, and observational studies of kidney biopsies in patients with AKI.

STUDY SELECTION: 

English language observational studies, randomized clinical trials, reviews, professional society recommendations, and guidelines on areas related to precision medicine in AKI.

DATA EXTRACTION: 

Relevant study results, statements, and guidelines were qualitatively assessed and narratively synthesized.

DATA SYNTHESIS: 

We synthesized relevant study results, professional society recommendations, and guidelines in this discussion.

CONCLUSIONS: 

AKI is a syndrome that encompasses a wide range of underlying pathologies, and this heterogeneity has hindered the development of novel therapeutics for AKI. Wide-ranging efforts to improve precision in AKI have included the validation of novel biomarkers of AKI, leveraging EHRs for disease classification, and phenotyping of tubular secretory clearance. Ongoing efforts such as the Kidney Precision Medicine Project, identifying subphenotypes in AKI, and optimizing clinical trials and endpoints all have great promise in advancing precision medicine in AKI.